CCRN4L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.391600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.828000E-01
Normal-vs-Stage2
6.441600E-01
Normal-vs-Stage3
4.982800E-01
Normal-vs-Stage4
1.677190E-01
Stage1-vs-Stage2
2.711500E-02
Stage1-vs-Stage3
5.544000E-01
Stage1-vs-Stage4
1.333200E-01
Stage2-vs-Stage3
4.023600E-01
Stage2-vs-Stage4
3.816200E-01
Stage3-vs-Stage4
6.684200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.292600E-01
Normal-vs-AfricanAmerican
6.859200E-01
Normal-vs-Asian
9.782800E-01
Caucasian-vs-AfricanAmerican
9.969400E-01
Caucasian-vs-Asian
3.426200E-01
AfricanAmerican-vs-Asian
5.399600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.999200E-01
Normal-vs-Female
5.591800E-01
Male-vs-Female
5.673400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.351400E-01
Normal-vs-Age(41-60Yrs)
3.184400E-01
Normal-vs-Age(61-80Yrs)
8.258200E-01
Normal-vs-Age(81-100Yrs)
2.049600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.870300E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.188420E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.682340E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.422880E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.19040000001736E-06
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.935500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.836400E-01
Normal-vs-Daily Drinker
7.503400E-01
Normal-vs-Weekly Drinker
5.329400E-01
Normal-vs-Occasional Drinker
7.336600E-01
Normal-vs-Social Drinker
4.979200E-01
Non Drinker-vs-Daily Drinker
5.502000E-01
Non Drinker-vs-Weekly Drinker
1.788790E-01
Non Drinker-vs-Occasional Drinker
4.956800E-01
Non Drinker-vs-Social Drinker
1.708590E-01
Daily Drinker-vs-Weekly Drinker
1.152160E-01
Daily Drinker-vs-Occasional Drinker
2.171400E-01
Daily Drinker-vs-Social Drinker
8.716000E-02
Weekly Drinker-vs-Occasional Drinker
5.173400E-01
Weekly Drinker-vs-Social Drinker
8.021800E-01
Occasional Drinker-vs-Social Drinker
3.744600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.914200E-01
Normal-vs-Grade 2
9.445400E-01
Normal-vs-Grade 3
8.819000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.973800E-01
Grade 1-vs-Grade 3
5.404000E-01
Grade 1-vs-Grade 4
8.914200E-01
Grade 2-vs-Grade 3
2.085800E-01
Grade 2-vs-Grade 4
9.445400E-01
Grade 3-vs-Grade 4
8.819000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.053200E-01
Normal-vs-NonDiabetic
6.775600E-01
Diabetic-vs-NonDiabetic
8.309400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.081400E-01
Normal-vs-NoPancreatitis
6.827800E-01
Pancreatitis-vs-NoPancreatitis
7.727200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.608000E-01
Normal-vs-N1
6.053600E-01
N0-vs-N1
3.921200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.958600E-01
Normal-vs-TP53-NonMutant
5.262400E-01
TP53-Mutant-vs-TP53-NonMutant
9.946600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
